Search

Displaying results 4361 - 4370 of 8575 in total
  1. Drug

    AP5280

    go.drugbank.com/drugs/DB05112
    Experimental

    AP5280 is a novel N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer-bound platinum (Pt) therapeutic designed to increase the therapeutic index relative to conventional, small-molecule platinum agents.

  2. Drug

    Elranatamab

    go.drugbank.com/drugs/DB15395
    ApprovedInvestigational

    [L47820] Elranatamab was also approved by the European Commission on December 8, 2023.[L50437]

  3. Drug

    PF-4191834

    go.drugbank.com/drugs/DB11645
    Investigational

    PF-4191834 has been investigated for the basic science of Asthma.

  4. Drug

    Fedovapagon

    go.drugbank.com/drugs/DB11734
    Investigational

    Fedovapagon has been used in trials studying the treatment of Nocturia.

  5. Drug

    Brivanib alaninate

    go.drugbank.com/drugs/DB11865
    Investigational

    Brivanib alaninate has been investigated for the treatment of Colorectal Cancer.

  6. Drug

    Butylphthalide

    go.drugbank.com/drugs/DB12749
    Investigational

    Butylphthalide has been used in trials studying the prevention of Restenosis.

  7. Drug

    Daniquidone

    go.drugbank.com/drugs/DB12804
    Investigational

    Daniquidone has been used in trials studying the treatment of Neoplasms.

  8. Drug

    Prednimustine

    go.drugbank.com/drugs/DB12832
    Investigational

    Prednimustine has been used in trials studying the treatment of Lymphoma.

  9. Drug

    LY-377604

    go.drugbank.com/drugs/DB12858
    Investigational

    Ly377604 has been used in trials studying the treatment of Obesity.

  10. Drug

    Ezutromid

    go.drugbank.com/drugs/DB12888
    Investigational

    Ezutromid has been investigated for the treatment of Muscular Dystrophy, Duchenne.